Definitive Contract HSHQDC16CB0021

Award Date 8/5/16
Potential Completion Date 12/31/19
Potential Value $1.2M
Contracting Federal Agency
Office of Procurement Operations
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Irwindale, CA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate to Silver Lake Research Corporation, a for-profit small business manufacturer. The $999,169.20 cost-plus-fixed-fee contract is for research and development services to create and validate small molecule select agent toxin detection assays. The contract has an ultimate completion date of July 21, 2020 and was awarded on December 31, 2015. This contract is not set aside for any...
The Department of Homeland Security Science and Technology Directorate awarded a firm-fixed-price contract valued at $1,656,989.53 to Silver Lake Research Corporation, a for-profit organization and manufacturer of goods, for the rapid detection of high-priority foreign animal pathogens using enzyme-linked immunosorbent assay (ELISA)-derived hyperspecific monoclonal antibodies. This contract, which does not have a set-aside designation, is for the development of rapid testing innovations,...
This is a $599,999.40 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Silver Lake Research Corporation, doing business as Silver Lake Research Corp. The contract is for the development of EAP-derived monoclonal antibodies for phenotyping immune cells of animal models of disease. This work supports infectious disease research and response programs. The contract does not have a...
This $750,000 Small Business Innovation Research (SBIR) Phase II award was granted by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Silver Lake Research Corporation, doing business as Silver Lake Research Corp, a small business manufacturer of rapid testing innovations. The contract supports the development of reagents for immunologic analysis of non-mammalian and underrepresented mammalian models, as part of an...
This is a cost-plus-fixed-fee definitive contract awarded by the Department of Homeland Security (DHS) Science and Technology Directorate to Gate Scientific, Inc. for research and development services related to the development and validation of an instrumentless, molecular diagnostic device that can test for a multiplexed panel of pathogens. The contract, awarded on September 14, 2016, has a ceiling value of $999,724.00 and a completion date of September 29, 2018. The contract is not...
This is a Cost Plus Fixed Fee contract awarded by the Department of Homeland Security's Science and Technology Directorate to Signature Science LLC, a for-profit limited liability company, for the provision of Research and Development Services related to the development and delivery of customized, easily executable bioinformatics and statistical workflows to characterize complex, non-clinical metagenomes. The potential value of the contract is $1,484,027.31, with a completion date of November 7,...
This federal contract award, valued at $6,622,532.37, was granted by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Meso Scale Diagnostics LLC, a small business, for "HIGH THROUGHPUT BIOMARKER-BASED BIODOSIMETRY" research and development. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and has a period of performance ending on September 1, 2022. Meso Scale...
This is a cost-plus-fixed-fee definitive contract awarded by the Science and Technology Directorate of the Department of Homeland Security to Omni Array Biotechnology LLC, a for-profit limited liability company, for research and development services. The contract has a ceiling value of $199,860.09 and a period of performance ending on September 29, 2016. The contract is not designated as a set-aside. No further details about potential subcontractors or the specific nature of the research and...
Silver Lake Research Corporation, doing business as Silver Lake Research Corp., has been awarded a firm fixed price definitive contract valued at $600,000 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, Silver Lake will deliver EAP-derived monoclonal antibodies for immune targets involved in cell activation in hamsters, as requested in the original solicitation. The prime contractor will perform work in Irwindale, California....
The Department of Homeland Security awarded a $999,875.54 cost-plus-fixed-fee contract to Physical Sciences Inc., a for-profit research and development company, for the FY21 SBIR Phase II "Interferometric Reflectance Imaging Sensor for Rapid Multiplexed Biothreat Detection" project. This contract is part of the DHS Science and Technology Directorate and Countering Weapons of Mass Destruction Office's SBIR program, which is seeking small business solutions for various research topics...

This is a Cost Plus Fixed Fee contract awarded by the U.S. Department of Homeland Security (DHS) Science and Technology Directorate to Silver Lake Research Corporation, a small business, for research and development services related to the generation, validation, and characterization of new monoclonal antibodies reactive with a group of toxins. The contract has a ceiling value of $1,167,200.00 and an ultimate completion date of December 31, 2019. This award does not have a set-aside designation. The contract requires the contractor to use its proprietary EAP immunization system to generate the new monoclonal antibodies, and includes an option for the development and validation of rapid lateral flow assay tests for on-site detection of the target toxins. As a small business, Silver Lake Research Corporation has been awarded multiple prime federal contracts and grants from agencies such as the National Institutes of Health and DHS to support infectious disease research and response efforts.

Generated 4/2/25, 8:45 PM